로더
전자서명란
서명초기화
확인
[X]

스킵 네비게이션


산학협력 정보시스템 CODE

교원DB

교원DB

사진

박상인Sangin Park

학부(과)
임상병리학과
직위
조교수
분야(복수)
E-Mail
sipark@dhu.ac.kr
연구실
053-819-1352
연구ㆍ관심 분야
조직학, 진단세포학, 분자진단학, 법의학

학력

대구한의대학교 임상병리학과 (임상병리학사)
대구한의대학교 한의과대학 한의학과 석사과정 (이학석사)
대구한의대학교 한의과대학 한의학과 박사과정 (이학박사)

연구실적

[논문]
* The therapeutic potential of mRNA-encoded SFTSV human monoclonal antibody encapsulated lipid nanoparticle in vivo, Journal of Controlled Release, 2025
* Novel CXCR2 antibodies exhibit enhanced anti-tumor activity in pancreatic cancer, Biomedicine & Pharmacotherapy, 2025
* Immunogenicity and protection of a triple repeat domain Ⅲ mRNA vaccine against Zika virus. Vaccine, 2024
* Single Oral Dose Toxicity Study of Cheongmokpye in Mice, Pharmacognosy Research, 2024
* A Lipid Nanoparticle Platform Incorporating Trehalose Glycolipid for Exceptional mRNA Vaccine Safety, Bioactive Materials, 2024
* Intranasal Immunization with Recombinant Measles Virus-encoded SARS-CoV-2 Spike protein Confers Protective Immunity against COVID-19 in hamsters, Vaccine, 2024
* DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis, Diabetes and Metabolism Journal, 2024
* mRNA-HPV vaccine encoding E6 and E7 improves therapeutic potential for HPV-mediated cancers via subcutaneous immunization, Journal of Medical Virology, 2023
* mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice, NPJ VACCINES, 2023
* Analysis of the immunostimulatory effects of cytokine-expressing internal ribosome entry site-based RNA adjuvants and their applications, The Journal of Infectious Diseases, 2023
* Analyzing immune responses to varied mRNA and protein vaccine sequences, NPJ VACCINES, 2023
* Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV, Scientific Reports, 2023
* Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants, Vaccine, 2023
* Peptides derived from S and N proteins of SARS-CoV-2 induce T cell responses: a proof-of-concept for T-cell vaccines, Frontiers in Microbiology, 2021
* Effective inactivated influenza vaccine for the elderly using single-stranded RNA-based adjuvant, Scientific Reports, 2021
* Immunization with RBD-P2 and N protects against SARS-CoV-2 in non-human primates, Science Advances, 2021
외 다수

[특허]
* 항-베타 아밀로이드 항체 및 이의 용도
* 항-타우 단백질 항체 및 이의 용도

주요경력사항(산업활동, 위원, 멘토, 특강 등)

現 대구한의대학교 K-바이오헬스대학 임상병리학과 (2024.09~현재)
前 삼광바이오트리그룹 SML바이오팜 수석연구원/비임상평가팀장 (2022.06~2024.07)
前 (재)스크립스코리아항체연구원 신약개발지원센터 동물모델평가팀장 (2020.04~2022.06)
前 (주)바이오팜솔루션즈 약리독성연구실 선임연구원 (2019~2020)
前 대구한의대학교 한의과대학 해부학교실 연구원 (2014~2018)